These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2513147)

  • 1. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for managing the patient with acute non-Q-wave myocardial infarction.
    Boden WE
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III33-40. PubMed ID: 2575020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-channel blockers as adjuvant therapy postthrombolysis.
    Boden WE
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S102-6. PubMed ID: 1724997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction.
    Gibson RS
    Circulation; 1989 Dec; 80(6 Suppl):IV107-19. PubMed ID: 2574639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of ischemia in acute myocardial infarction].
    Kiowski W
    Schweiz Med Wochenschr; 1990 Oct; 120(42):1531-8. PubMed ID: 1978408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():15-20. PubMed ID: 2512883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.
    Théroux P; Grégoire J; Chin C; Pelletier G; de Guise P; Juneau M
    J Am Coll Cardiol; 1998 Sep; 32(3):620-8. PubMed ID: 9741502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolytic therapy in acute myocardial infarct].
    von Essen R
    Z Gesamte Inn Med; 1987 Sep; 42(17):486-91. PubMed ID: 3120430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q wave and Non-Q wave myocardial infarction after thrombolysis.
    Matetzky S; Barabash GI; Rabinowitz B; Rath S; Zahav YH; Agranat O; Kaplinsky E; Hod H
    J Am Coll Cardiol; 1995 Nov; 26(6):1445-51. PubMed ID: 7594069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive therapy in coronary thrombolysis: prostaglandins, nitrates and calcium antagonists.
    Fitzgerald D
    Coron Artery Dis; 1995 Dec; 6(12):940-6. PubMed ID: 8723016
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Rothbaum DA; Hodes ZI; Linnemeier TJ; Landin RJ; Ball MW
    Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus late opening of coronary arteries: the effect of timing.
    Rapaport E
    Clin Cardiol; 1990 Aug; 13(8 Suppl 8):VIII18-22. PubMed ID: 2145108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.